Table 1 Basic characteristics for hemodialysis patients versus the comparison patients
Variable | HD patients | Comparison patients | p value | ||
|---|---|---|---|---|---|
n=796 | n=3184 | ||||
n | % | n | % | ||
Gender | |||||
Male | 365 | 45.85 | 1460 | 45.85 | - |
Female | 431 | 54.15 | 1724 | 54.15 | |
Age (mean±SD) | 56.72±13.75 | 56.72±13.74 | - | ||
< 50 | 241 | 30.28 | 964 | 30.28 | 0.99 |
50-64 | 296 | 37.19 | 1184 | 37.19 | |
65-74 | 200 | 25.13 | 798 | 25.06 | |
> 74 | 59 | 7.41 | 238 | 7.47 | |
Hypertension | |||||
Yes | 566 | 71.11 | 1032 | 32.41 | < 0.001 |
No | 230 | 28.89 | 2152 | 67.59 | |
Diabetes | |||||
Yes | 288 | 36.18 | 395 | 12.41 | < 0.001 |
No | 508 | 63.82 | 2789 | 87.59 | |
Coronary heart disease | |||||
Yes | 162 | 20.35 | 372 | 11.68 | < 0.001 |
No | 634 | 79.65 | 2812 | 88.32 | |
Hyperlipidemia | |||||
Yes | 145 | 18.22 | 446 | 14.01 | 0.003 |
No | 651 | 81.78 | 2738 | 85.99 | |
Liver cirrhosis | |||||
Yes | 20 | 2.51 | 33 | 1.04 | 0.001 |
No | 776 | 97.49 | 3151 | 98.96 | |
HP eradication | |||||
Yes | 54 | 6.78 | 201 | 6.31 | 0.627 |
No | 776 | 97.49 | 3151 | 98.96 | |
Aspirin use (gm/person-year) | 11.28±35.76 | 13.05±47.29 | 0.247 | ||
NSAIDs use (DDDs/person-year) | 14.72±29.54 | 41.99±75.14 | < 0.001 | ||
PPI use (DDDs/person-year) | 16.15±184.80 | 3.02±16.39 | < 0.001 | ||
H2RAs use (DDDs/person-year) | 6.97±21.30 | 5.60±18.44 | 0.490 | ||